Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

United States comparative costs and absenteeism of diabetic ophthalmic conditions.

Brook RA, Kleinman NL, Patel S, Smeeding JE, Beren IA, Turpcu A.

Postgrad Med. 2014 Dec 31:1-8. [Epub ahead of print]

PMID:
25549691
2.

Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism.

Kleinman NL, Odell K, Chen CI, Atkinson A, Zou KH.

J Manag Care Pharm. 2014 Oct;20(10):1047-56.

3.

Economic burden of back and neck pain: effect of a neuropathic component.

Kleinman N, Patel AA, Benson C, Macario A, Kim M, Biondi DM.

Popul Health Manag. 2014 Aug;17(4):224-32. doi: 10.1089/pop.2013.0071. Epub 2014 Mar 31.

PMID:
24684443
4.

Economic burden of urge urinary incontinence in the workplace.

Kleinman NL, Chen CI, Atkinson A, Odell K, Zou KH.

J Occup Environ Med. 2014 Mar;56(3):266-9. doi: 10.1097/JOM.0000000000000085.

PMID:
24603202
5.

Cohort analysis assessing medical and nonmedical cost associated with obesity in the workplace.

Kleinman N, Abouzaid S, Andersen L, Wang Z, Powers A.

J Occup Environ Med. 2014 Feb;56(2):161-70. doi: 10.1097/JOM.0000000000000099.

PMID:
24451611
6.

Work-related and health care cost burden of community-acquired pneumonia in an employed population.

Kleinman NL, Yu H, Beren IA, Sato R.

J Occup Environ Med. 2013 Oct;55(10):1149-56. doi: 10.1097/JOM.0b013e3182a7e6af.

PMID:
24064787
7.

Direct and indirect costs of women diagnosed with menopause symptoms.

Kleinman NL, Rohrbacker NJ, Bushmakin AG, Whiteley J, Lynch WD, Shah SN.

J Occup Environ Med. 2013 Apr;55(4):465-70. doi: 10.1097/JOM.0b013e3182820515.

PMID:
23532198
8.

Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis.

Kleinman NL, Cifaldi MA, Smeeding JE, Shaw JW, Brook RA.

J Occup Environ Med. 2013 Mar;55(3):240-4. doi: 10.1097/JOM.0b013e318282d310.

PMID:
23471034
9.

Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks.

Lynch W, Chan W, Kleinman N, Andrews LM, Yadao AM.

Popul Health Manag. 2013 Apr;16(2):138-45. doi: 10.1089/pop.2012.0057. Epub 2012 Oct 31.

PMID:
23113634
10.

Costs, work absence, and adherence in patients with partial onset seizures prescribed gabapentin or pregabalin.

Kleinman NL, Sadosky A, Seid J, Martin RC, Labiner DM.

Epilepsy Res. 2012 Nov;102(1-2):13-22. doi: 10.1016/j.eplepsyres.2012.04.019. Epub 2012 May 14.

PMID:
22591752
11.

Absenteeism and productivity among employees being treated for hepatitis C.

Brook RA, Kleinman NL, Su J, Corey-Lisle PK, Iloeje UH.

Am J Manag Care. 2011 Oct;17(10):657-64.

PMID:
22106459
12.

Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population.

Brook RA, Kleinman NL, Choung RS, Smeeding JE, Talley NJ.

Dig Dis Sci. 2012 Jan;57(1):109-18. doi: 10.1007/s10620-011-1822-8. Epub 2011 Jul 13.

PMID:
21750928
13.

Economic impact to employers of treatment options for cardiac arrhythmias in the US health system.

Kleinman NL, Rohrbacker NJ, White SA, March JL, Reynolds MR.

J Occup Environ Med. 2011 Apr;53(4):405-14. doi: 10.1097/JOM.0b013e31820fd1c9.

PMID:
21407098
14.

Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care.

Kleinman NL, Sanchez RJ, Lynch WD, Cappelleri JC, Beren IA, Joshi AV.

Pain Pract. 2011 Nov-Dec;11(6):540-51. doi: 10.1111/j.1533-2500.2011.00453.x. Epub 2011 Mar 10.

PMID:
21392253
15.

Comparing costs and absences for multiple sclerosis among US employees: pre- and post-treatment initiation.

Rajagopalan K, Brook RA, Beren IA, Kleinman NL.

Curr Med Res Opin. 2011 Jan;27(1):179-88. doi: 10.1185/03007995.2010.540006. Epub 2010 Dec 7.

PMID:
21138336
16.

Medication adherence with disease modifying treatments for multiple sclerosis among US employees.

Kleinman NL, Beren IA, Rajagopalan K, Brook RA.

J Med Econ. 2010;13(4):633-40. doi: 10.3111/13696998.2010.527588. Epub 2010 Oct 19.

PMID:
20958113
17.

The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs.

Su J, Brook RA, Kleinman NL, Corey-Lisle P.

Hepatology. 2010 Aug;52(2):436-42. doi: 10.1002/hep.23726.

PMID:
20683943
18.

The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: associated costs, absences, and objective productivity loss.

Rohrbacker NJ, Kleinman NL, White SA, March JL, Reynolds MR.

J Occup Environ Med. 2010 Apr;52(4):383-91. doi: 10.1097/JOM.0b013e3181d967bc.

PMID:
20357675
19.

Functional dyspepsia impacts absenteeism and direct and indirect costs.

Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):498-503. doi: 10.1016/j.cgh.2010.03.003. Epub 2010 Mar 19.

PMID:
20304102
20.

Effect of antihypertensive medication adherence among employees with hypertension.

Lynch WD, Markosyan K, Melkonian AK, Pesa J, Kleinman NL.

Am J Manag Care. 2009 Dec;15(12):871-80.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk